Systematic review of mTOR inhibitor treatment, biomarkers and prophylaxis for tuberous sclerosis complex-associated seizures

被引:0
|
作者
Zhang, Jingwen [1 ]
机构
[1] Kings Coll London GKT Sch Med Educ, London, England
关键词
EVEROLIMUS; EPILEPSY; ONSET;
D O I
10.7861/clinmed.22-4-s48
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S48 / S49
页数:2
相关论文
共 50 条
  • [41] Mammalian target of rapamycin inhibitor and transarterial embolization of tuberous sclerosis complex-associated renal angiomyolipoma: A case series
    Hsiao, Wei-Chung
    Hsieh, Tzuo-Yi
    Chen, Wen-Jung
    Wang, Shao-Chuan
    Kao, Yu-Lin
    Tsai, Jeng-Dau
    Chen, Sung-Lang
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 18 - 18
  • [42] DISEASE BURDEN IN EPILEPSY ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: SYSTEMATIC REVIEW
    Blieden, M.
    Parker, L.
    Foster, T.
    Segal, S.
    Magestro, M.
    VALUE IN HEALTH, 2013, 16 (07) : A618 - A618
  • [43] Effects of everolimus on tuberous sclerosis complex-associated renal angiomyolipoma: A preliminary report
    Tsai, Jeng-Dau
    Wei, Chang-Ching
    Yang, Sheng-Hui
    Fan, Hueng-Chuen
    Hsu, Chih-Chuan
    Tung, Min-Che
    Tsai, Min-Ling
    Sheu, Ji-Nan
    NEPHROLOGY, 2017, 22 (12) : 1017 - 1022
  • [44] Best use of the tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) checklist
    de Vries, Petrus J.
    Jansen, Anna
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2019, 61 (02): : 112 - 113
  • [45] A Comparison of Clinical and Radiological Presentations of Sporadic and Tuberous Sclerosis Complex-Associated Lymphangioleiomyomatosis
    Savage, Taylor E.
    Geenen, Kennedy R.
    Price, Melissa C.
    El-Chemaly, Souheil Y.
    Henske, Elizabeth P.
    Sharma, Amita
    Thiele, Elizabeth A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2024,
  • [46] Enhancing the utility of tuberous sclerosis complex-associated neuropsychiatric disorders checklist in China
    Zhang Jing
    Zhu Gang
    Liang Yan
    Wan Lin
    Liu Xinting
    Yan Huimin
    Liu Guoyin
    Zhang Bo
    Yang Guang
    儿科学研究(英文), 2024, 08 (03)
  • [47] Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas
    Fackler, I
    DeClue, JE
    Rust, H
    Vu, PA
    Kutzner, H
    Rütten, A
    Kaddu, S
    Sander, CA
    Volkenandt, M
    Johnson, MW
    Vinters, HV
    Wienecke, R
    JOURNAL OF CUTANEOUS PATHOLOGY, 2003, 30 (03) : 174 - 177
  • [48] Enhancing the utility of tuberous sclerosis complex-associated neuropsychiatric disorders checklist in China
    Zhang, Jing
    Zhu, Gang
    Liang, Yan
    Wan, Lin
    Liu, Xinting
    Yan, Huimin
    Liu, Guoyin
    Zhang, Bo
    Yang, Guang
    PEDIATRIC INVESTIGATION, 2024, 8 (03) : 171 - 176
  • [49] Pharmacologic management of tuberous sclerosis complex-associated subependymal giant cell astrocytomas
    Franz, David Neal
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (01): : 53 - 66
  • [50] mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex
    Franz, David Neal
    Krueger, Darcy Andrew
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2018, 178 (03) : 365 - 373